Sands Capital Management
BLUE

Sands Capital Management’s bluebird bio BLUE Stock Holding History

Sands Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-244,234
Closed -$137M – 76
2020
Q4 		$137M Sell
244,234
-2,475
-1% -$1.57M 0.26% 54
2020
Q3 		$172M Buy
246,709
+5,030
+2% +$3.92M 0.37% 50
2020
Q2 		$191M Buy
241,679
+808
+0.3% +$609K 0.46% 47
2020
Q1 		$143M Sell
240,871
-4,366
-2% -$4.25M 0.48% 43
2019
Q4 		$279M Buy
245,237
+76,928
+46% +$83.6M 0.81% 35
2019
Q3 		$200M Buy
168,309
+82,730
+97% +$126M 0.64% 38
2019
Q2 		$141M Buy
+85,579
New +$148M 0.42% 42

Other funds holding BLUE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Sands Capital Management's BLUE Position: Q1 2021 in Review

Sands Capital Management sold out of bluebird bio (BLUE) in Q1 2021, closing a stake of 244,234 shares — an estimated $137M sold.

Sands Capital Management first reported a position in BLUE in Q2 2019 and held it in 7 quarters. The position peaked at $279M in Q4 2019. 229 funds tracked by Wall St. Rank hold BLUE as of Q1 2021.

  • Sands Capital Management reported no remaining bluebird bio position as of Q1 2021 after selling out during the quarter.
  • Sands Capital Management sold 244,234 bluebird bio shares in Q1 2021, an estimated $137M.
  • Sands Capital Management first reported a position in bluebird bio in Q2 2019 and held it in 7 quarters.
  • Sands Capital Management's bluebird bio position peaked at $279M in Q4 2019.
  • 229 funds tracked by Wall St. Rank held bluebird bio as of Q1 2021.

Based on Sands Capital Management's 13F filing for Q1 2021, filed 12 May 2021.